These results provide the foundation for future studies investigating the role MCT1 plays in adipocyte hyperplasia, and its therapeutic potential as a drug target for obesity and metabolic disease. The gene discussed is SLC16A1; the disease is obesity due to melanocortin 4 receptor deficiency.